4395 |
Adherence Management Framework |
25/07/2023 |
Adherence |
4405 |
Adherence Monitoring Methods - Manual |
25/07/2023 |
Adherence |
4399 |
Adherence Quality Indicators |
25/07/2023 |
Adherence |
3344 |
Adherence Register |
26/07/2023 |
Adherence, NIKSHAY |
816 |
Adherence Summary Dashboard |
26/07/2023 |
Adherence, NIKSHAY, Monitoring and Evaluation |
4398 |
Adherence Terminology & Program Updates |
26/07/2023 |
Adherence |
226 |
Administrative measures for AIC at a Health Facility |
26/07/2023 |
TB prevention including airborne infection control, Admin related matters |
4798 |
ADR: Hearing Loss/ Ototoxicity |
26/07/2023 |
Drug resistant TB management, Surveillance |
4934 |
ADRs due to TPT |
26/07/2023 |
Surveillance, TB preventive treatment |
3241 |
aDSM review form |
26/07/2023 |
Surveillance, Drug resistant TB management |
3242 |
aDSM treatment initiation form |
26/07/2023 |
Drug resistant TB management, Surveillance, Monitoring and Evaluation |
1238 |
Advantages and Limitations of TB Diagnostic Culture Methods |
26/07/2023 |
Laboratory services and management |
562 |
Advantages of FDCs |
26/07/2023 |
Procurement and supply chain management- Drugs, Diagnostics and services |
1113 |
Adverse Drug Events: H Mono/Poly DR-TB Regimen |
26/07/2023 |
Drug resistant TB management, Monitoring and Evaluation |
28 |
Adverse Drug Reactions |
26/07/2023 |
Monitoring and Evaluation, Surveillance |
1107 |
Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen |
26/07/2023 |
Drug resistant TB management, Monitoring and Evaluation, Surveillance |
625 |
Adverse Drug Reactions(ADRs) to First Line Treatment |
26/07/2023 |
Monitoring and Evaluation, Surveillance, Drug sensitive TB |
626 |
Adverse Drug Reactions(ADRs) to Second Line Treatment |
26/07/2023 |
Drug resistant TB management, Monitoring and Evaluation, Surveillance |
1909 |
Adverse Event Definitions and Classifications |
26/07/2023 |
Monitoring and Evaluation, Surveillance |
3210 |
Advocacy to affected communities and PLHA networks |
26/07/2023 |
Advocacy communication and social mobilization, Tb Comorbidities, Multi-sectoral engagement and inter ministerial collaboration |
334 |
Agent in TB |
26/07/2023 |
TB epidemiology |
1080 |
Aims and Objectives of Screening for Active TB |
26/07/2023 |
Active case finding |
167 |
Air drying and heat fixing |
26/07/2023 |
Laboratory services and management |
74 |
Airborne Infection Control [AIC] |
26/07/2023 |
TB prevention including airborne infection control, TB epidemiology, Admin related matters |
4363 |
Ambulance services during Referral |
26/07/2023 |
Admin related matters |
1291 |
Amplification and Detection of MTB and MTB-Rif |
26/07/2023 |
Laboratory services and management |
1944 |
Amplification of Extracted DNA in the LPA Lab |
26/07/2023 |
Laboratory services and management |
3720 |
Analysing DBT Reports for performance |
26/07/2023 |
DBT, NIKSHAY, Monitoring and Evaluation |
1920 |
Annual Maintenance of the Truenat Instrument |
26/07/2023 |
Laboratory services and management |
184 |
Annual Maintenance [AMC] of a Microscope |
26/07/2023 |
Laboratory services and management |